Inventor
CUNNINGHAM BRIAN C
US32 patents
⚠️ This page may combine multiple inventors who share the name “CUNNINGHAM BRIAN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
23 patentsUS6451561B1Sep 17, 2002
Growth hormone variants
GENENTECH INC96 citations99
US6022711AFeb 8, 2000
Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1
GENENTECH INC100 citations99
US6013478AJan 11, 2000
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC184 citations99
US5834250ANov 10, 1998
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC432 citations99
US5580723ADec 3, 1996
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC212 citations99
US5534617AJul 9, 1996
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
GENENTECH INC236 citations99
US6800740B1Oct 5, 2004
Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications
GENENTECH INC77 citations98
US6428954B1Aug 6, 2002
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC94 citations98
US6057292AMay 2, 2000
Method for inhibiting growth hormone action
GENENTECH INC198 citations98
US5849535ADec 15, 1998
Human growth hormone variants
GENENTECH INC346 citations98
US6057428AMay 2, 2000
Variants of vascular endothelial cell growth factor
GENENTECH INC90 citations97
US6780613B1Aug 24, 2004
Growth hormone variants
GENENTECH INC49 citations96
US6143523ANov 7, 2000
Human growth hormone variants
GENENTECH INC84 citations96
US5955346ASep 21, 1999
Variants of human prolactin and human placeatal lactogen
GENENTECH INC54 citations96
US5854026ADec 29, 1998
Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1
GENENTECH INC78 citations96
US6136563AOct 24, 2000
Human growth hormone variants comprising amino acid substitutions
GENENTECH INC67 citations95
US6004931ADec 21, 1999
Method for inhibiting growth hormone action
GENENTECH INC85 citations95
US5846932ADec 8, 1998
Receptor specific atrial natriuretic peptides
GENENTECH INC79 citations95
US5506107AApr 9, 1996
Selecting ligand agonists and antagonists
GENENTECH INC167 citations95
US6936440B1Aug 30, 2005
Selecting ligand agonists and antagonists
GENENTECH INC25 citations93
US6525022B1Feb 25, 2003
Receptor specific atrial natriuretic peptides
GENENTECH INC35 citations92
US5665704ASep 9, 1997
Receptor specific atrial natriuretic peptides
GENENTECH INC56 citations92
US7090834B1Aug 15, 2006
Vascular endothelial cell growth factor variants and uses thereof
GENENTECH INC7 citations68
GENENCOR INT
6 patentsUS5955340ASep 21, 1999
Modified subtilisins having amino acid alterations
GENENCOR INT241 citations98
US5700676ADec 23, 1997
Modified subtilisins having amino acid alterations
GENENCOR INT335 citations98
US5972682AOct 26, 1999
Enzymatically active modified subtilisins
GENENCOR INT62 citations95
US5801038ASep 1, 1998
Modified subtilisins having amino acid alterations
GENENCOR INT59 citations95
US5763257AJun 9, 1998
Modified subtilisins having amino acid alterations
GENENCOR INT63 citations95
US6465235B1Oct 15, 2002
Non-human carbonyl hydrolase mutants, DNA sequences and vectors encoding same and hosts transformed with said vectors
GENENCOR INT32 citations92